T1	Participants 78 96	nephroureterectomy
T3	Participants 351 414	nephroureterectomy for upper urinary tract urothelial carcinoma
T4	Participants 763 795	36 patients in the control group
T2	Participants 159 232	Pirarubicin Monotherapy Study Group trial was a randomized Phase II study
